Landscape of somatic retrotransposition in human cancers

Science

Volumn 337, Issue 6097, 2012, Pages 967-971

  Lee, Eunjung ^a,b   Iskow, Rebecca ^b   Yang, Lixing ^a   Gokcumen, Omer ^b   Haseley, Psalm ^a,b   Luquette III, Lovelace J ^a   Lohr, Jens G ^c,d   Harris, Christopher C ^e   Ding, Li ^e   Wilson, Richard K ^e   Wheeler, David A ^f   Gibbs, Richard A ^f   Kucherlapati, Raju ^b,g   Lee, Charles ^b   Kharchenko, Peter V ^a,h   Park, Peter J ^a,b,h  

^a Harvard Medical School Center for Biomedical Informatics   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CANCER; CYTOLOGY; DATA SET; DNA; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; GENOMICS; MUTATION; PUBLIC HEALTH; TUMOR;

ARTICLE; BRAIN CANCER; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPITHELIUM TUMOR; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HEMATOLOGIC MALIGNANCY; HUMAN; LANDSCAPE; NEOPLASM; PRIORITY JOURNAL; TRANSPOSON;

EID: 84865285978     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1222077     Document Type: Article

References (25)

1. J. M. Kidd et al., Cell 143, 837 (2010).
2. I. A. Maksakova, D. L. Mager, D. Reiss, Cell. Mol. Life Sci. 65, 3329 (2008).
3. R. K. Slotkin, R. Martienssen, Nat. Rev. Genet. 8, 272 (2007).
4. N. Yang, H. H. Kazazian Jr., Nat. Struct. Mol. Biol. 13, 763 (2006).
5. E. T. L. Prak, H. H. Kazazian Jr., Nat. Rev. Genet. 1, 134 (2000).
6. D. Bourc'his, T. H. Bestor, Nature 431, 96 (2004).
7. A. Molaro et al., Cell 146, 1029 (2011).
8. J. K. Baillie et al., Nature 479, 534 (2011).
9. D. C. Hancks, H. H. Kazazian Jr., Curr. Opin. Genet. Dev. 22, 191 (2012).
10. Y. Miki et al., Cancer Res. 52, 643 (1992).
11. R. C. Iskow et al., Cell 141, 1253 (2010).
12. P. J. Hastings, G. Ira, J. R. Lupski, PLoS Genet. 5, e1000327 (2009).
13. CRA00R was excluded from this assessment because the event frequency in this tumor was underestimated as a result of a data quality issue in the matched normal sample (see materials and methods).
14. G. Poulogiannis et al., Proc. Natl. Acad. Sci. U.S.A. 107, 15145 (2010).
15. Z. Jin et al., Oncogene 26, 6332 (2007).
16. M. L. Slovak et al., Clin. Cancer Res. 17, 3443 (2011).
17. R. E. Dickinson, K. S. Fegan, X. Ren, S. G. Hillier, W. C. Duncan, PLoS One 6, e27792 (2011).
18. H. Izumi et al., Hum. Mol. Genet. 14, 997 (2005).
19. R. Beroukhim et al., Proc. Natl. Acad. Sci. U.S.A. 104, 20007 (2007).
20. H. Zheng et al., Cancer Cell 17, 497 (2010).
21. J. S. Han, S. T. Szak, J. D. Boeke, Nature 429, 268 (2004).
22. M. L. Lin et al., Cancer Sci. 100, 1443 (2009).
23. C. R. Beck et al., Cell 141, 1159 (2010).
24. A. D. Ewing, H. H. Kazazian Jr., Genome Res. 20, 1262 (2010).
25. A. D. Ewing, H. H. Kazazian Jr., Genome Res. 21, 985 (2011).